Back to Top
Announcements

Aims & Scope


Biotechnology Law Report delivers critical authoritative analysis of biotech patents and litigation, regulatory and legislative activity, and trade-related aspects of biotechnology. As the first journal in the field of biotechnology law nearly 40 years ago, it provides exclusive access to historic developments that are informing legal cases today. The Journal is particularly devoted to industries in which new biotechology products are developing the most rapidly: pharmaceuticals, chemicals, agriculture, food processing, energy, mineral recovery, and waste treatment. Biotechnology Law Report is highly recommended for law firms or corporate legal department library collections contributing research services to biotechnology research or a patent law practice.

Biotechnology Law Report coverage includes:

  • Pharmaceutical regulatory affairs
  • Agricultural and environmental regulatory affairs
  • Patents and patent litigation
  • Licensing and collaborations
  • Financial and shareholder news
  • Meeting Notices

Audience: Biotechnology patent officers, agricultural and environmental researchers and specialists, biotechnology lawyers, among others

Indexing/Abstracting:

  • PubMed Central
  • Web of Science: Science Citation Index Expanded™ (SCIE)
  • Scopus
  • Biotechnology Citation Index®
  • Journal Citation Reports/Science Edition
  • EMBiology
  • ProQuest databases
  • CAB Abstracts
  • Biocommerce Abstracts
  • BenchSci
The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.